Hohenheim Malnutrition Study in Geriatric Fracture Patients
NCT ID: NCT03493100
Last Updated: 2018-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
106 participants
INTERVENTIONAL
2016-09-15
2018-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of a Nutritional Supplement in an Older Malnourished or at Risk of Malnutrition, Hip Fracture Population
NCT03882944
Bone Intake Proteins and Muscle Mass Deficiency in Proximal Femur Fractures
NCT05804604
A Natural History Study of Bone and Mineral Disorders
NCT00024804
Bone Loss in Patients With Anorexia Nervosa
NCT01907464
Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years
NCT02891356
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oral nutritional supplementation
This group receives optimized nutritional support, by ONS for a period of four weeks.
oral nutritional supplementation
The intervention group will receive optimized nutritional support, by ONS. While hospitalized each patient receives 2 portions of oral supplementation per day. For remaining days supplementation is calculated individually according to a sarcopenia/energy balance schema resulting in none or maximum 2 portions per day.
Control
The control group will receive treatment according to usual care.
Usual care
The control group will receive treatment according to usual care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral nutritional supplementation
The intervention group will receive optimized nutritional support, by ONS. While hospitalized each patient receives 2 portions of oral supplementation per day. For remaining days supplementation is calculated individually according to a sarcopenia/energy balance schema resulting in none or maximum 2 portions per day.
Usual care
The control group will receive treatment according to usual care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥ 65 years and Carlson-Comorbidity-Index of ≥ 5 and
* written informed consent
Exclusion Criteria
* relevant pre-existing chronic conditions (in order to avoid disease related impact on outcome parameters)
* insufficient German speech intelligibility
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Hohenheim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephan C. Bischoff
Role: PRINCIPAL_INVESTIGATOR
University of Hohenheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Hohenheim
Stuttgart, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HohMal2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.